Cargando…
Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer
SIMPLE SUMMARY: Ovarian cancer is the eighth most common cancer among women and has a 5-year survival of only 30–50%. The survival is close to 90% for patients in stage I but only 20% for patients in stage IV. The presently available biomarkers have insufficient sensitivity and specificity for early...
Autores principales: | Gyllensten, Ulf, Hedlund-Lindberg, Julia, Svensson, Johanna, Manninen, Johanna, Öst, Torbjörn, Ramsell, Jon, Åslin, Matilda, Ivansson, Emma, Lomnytska, Marta, Lycke, Maria, Axelsson, Tomas, Liljedahl, Ulrika, Nordlund, Jessica, Edqvist, Per-Henrik, Sjöblom, Tobias, Uhlén, Mathias, Stålberg, Karin, Sundfeldt, Karin, Åberg, Mikael, Enroth, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997113/ https://www.ncbi.nlm.nih.gov/pubmed/35406529 http://dx.doi.org/10.3390/cancers14071757 |
Ejemplares similares
-
Data-driven analysis of a validated risk score for ovarian cancer identifies clinically distinct patterns during follow-up and treatment
por: Enroth, Stefan, et al.
Publicado: (2022) -
Preoperative Fasting and General Anaesthesia Alter the Plasma Proteome
por: Gyllensten, Ulf, et al.
Publicado: (2020) -
A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer
por: Enroth, Stefan, et al.
Publicado: (2018) -
High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer
por: Enroth, Stefan, et al.
Publicado: (2019) -
Next generation pan-cancer blood proteome profiling using proximity extension assay
por: Álvez, María Bueno, et al.
Publicado: (2023)